Highlights of the Upcoming ACR 2011 Annual Meeting - Medscape

Highlights of the Upcoming ACR 2011 Annual Meeting Medscape Some global themes to be explored during the meeting are pain, new longitudinal data on osteoarthritis (OA), and new targets in rheumatoid arthritis (RA). "Rheumatic diseases are painful conditions, and this year we are providing comprehensive sessions ... Better alignment could cut need for hip replacementsCNN all 2 news articles »

Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be ... - MarketWatch (press release)

Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be ... MarketWatch (press release) Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis, pain, cholesterol reduction, allergic and immune ... and more »

Arthritis a forgotten disease in Canada, says group - CTV.ca

CBC.ca

Arthritis a forgotten disease in Canada, says group CTV.ca Improved pain management for people with osteoarthritis; savings of 8 billion. Earlier diagnosis and treatment of rheumatoid arthritis; savings of billion. The alliance is calling on government policy-makers, the corporate sector and the ... New Report Indicates Arthritis is a Billion Burden on CanadiansCanada NewsWire (press release) Arthritis costs Canada B a yearCBC.ca Arthritis, a forgotten diseaseCastanet.net all 39 news articles »

Vertex Announces Presentation of New Data for Oral JAK3 Inhibitor VX-509 at ... - EON: Enhanced Online News (press release)

Vertex Announces Presentation of New Data for Oral JAK3 Inhibitor VX-509 at ... EON: Enhanced Online News (press release) The development of disability in rheumatoid arthritis. Arthritis Rheum. 1986;29:494-500. 4. Callahan LF, Brooks RH, Summey JA, Pincus T. Quantitative pain assessment for routine care of rheumatoid arthritis patients, using a pain scale based on ... Vertex Announces Presentation of New Data for Oral JAK3 Inhibitor VX-509 at ...MarketWatch (press release) all 8 news articles »